Moderna Reports Positive Results from Cancer Vaccine-Keytruda Combination Trial

Key TakeawaysModerna reported positive results of a small-sample trial of its experimental individualized cancer vaccine and Merck's Keytruda to treat those with head and neck cancers.The study found the combination boosted the immune response in patients.Moderna said research on using the treatment in a more advanced disease setting may be warranted. Moderna (MRNA) shares jumped Tuesday after the biotech firm reported positive results from a small trial involving those with head and neck cancers treated wi ...